Fulgent Genetics, Inc. (FLGT)
24.39
-0.39
(-1.57%)
USD |
NASDAQ |
Nov 20, 10:10
Fulgent Genetics Cash from Operations (Quarterly) : 109.23M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 109.23M |
| June 30, 2026 | -23.76M |
| March 31, 2026 | 7.097M |
| December 31, 2025 | -78.14M |
| September 30, 2025 | 11.11M |
| June 30, 2025 | -30.17M |
| March 31, 2025 | -4.431M |
| December 31, 2024 | 25.02M |
| September 30, 2024 | -15.51M |
| June 30, 2024 | 4.285M |
| March 31, 2024 | 7.266M |
| December 31, 2023 | 14.93M |
| September 30, 2023 | 10.24M |
| June 30, 2023 | 9.737M |
| March 31, 2023 | -7.907M |
| December 31, 2022 | 33.21M |
| September 30, 2022 | 20.78M |
| June 30, 2022 | 11.13M |
| March 31, 2022 | 188.41M |
| December 31, 2021 | 77.10M |
| September 30, 2021 | 152.19M |
| June 30, 2021 | 76.12M |
| Date | Value |
|---|---|
| March 31, 2021 | 233.18M |
| December 31, 2020 | 134.26M |
| September 30, 2020 | 9.415M |
| June 30, 2020 | -4.409M |
| March 31, 2020 | 1.366M |
| December 31, 2019 | -0.116M |
| September 30, 2019 | 3.903M |
| June 30, 2019 | 0.675M |
| March 31, 2019 | 1.055M |
| December 31, 2018 | 0.778M |
| September 30, 2018 | -0.105M |
| June 30, 2018 | -0.057M |
| March 31, 2018 | -1.291M |
| December 31, 2017 | -1.241M |
| September 30, 2017 | 0.50M |
| June 30, 2017 | 1.365M |
| March 31, 2017 | 0.707M |
| December 31, 2016 | 1.254M |
| September 30, 2016 | 0.798M |
| June 30, 2016 | 1.478M |
| March 31, 2016 | 0.875M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 611.00M |
| Labcorp Holdings, Inc. | 563.80M |
| OPKO Health, Inc. | -36.32M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | -8.885M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -48.04M |
| Cash from Financing (Quarterly) | -0.724M |
| Free Cash Flow | -1.40M |
| Free Cash Flow Per Share (Quarterly) | 3.884 |
| Free Cash Flow to Equity (Quarterly) | 106.68M |
| Free Cash Flow to Firm (Quarterly) | 107.45M |
| Free Cash Flow Yield | -0.21% |